
Many federal employees and their dependents may be anxious about paying their medical bills.

Many federal employees and their dependents may be anxious about paying their medical bills.

My genetic counselor told me that saving a blood sample allows you to designate access to it by family members for genetic testing for hereditary cancers years down the road. You can make a difference to help loved ones.

23andMe received Food and Drug Administration (FDA) clearance for a genetic health risk report on a hereditary colorectal cancer syndrome, according to the genetics company.

Penn Medicine launches program that allows people with brain tumors to access remote medical plans.

I'll look less like a woman, but I'll feel more like one.

A man with glioblastoma has received Gliovac (ERC1671) under legislation allowing for the terminally ill to try experimental drugs that have passed preliminary FDA testing.

I am a person who always was able to sleep and would generally be out before my head ever hit the pillow. Now I found myself tossing and turning for hours at a time.

There is a flood of information available about genetic tests for cancer risk in the media, and even at community events, such as health fairs and senior centers. If these promotions have caught your attention and you are considering testing, there is important information that you should know first.

Here’s a resource for what FDA decisions mean – and how they affect patients.

Winter can aggravate this chemotherapy side effect that causes hands and feet to feel numb, tingly and painful.

Magic that occurs when we write.

Travel choices can be healthy, if a bit nerve-wracking, for a cancer survivor.

When I began my medical oncology career more than 30 years ago, I was determined to be among the first generation of researchers to cure cancer.

The FDA has granted an approval to Ontruzant (SB3; trastuzumab -dttb), a Herceptin (trastuzumab) biosimilar, for the treatment of patients with HER2-overexpressing breast cancer or metastatic gastric or gastroesophageal junction adenocarcinoma.

The addition of the investigational drug alisertib to a paclitaxel regimen showed promising activity in patients with recurrent ovarian cancer or advanced breast cancer.

Although chemotherapy and radical cystectomy are traditionally used to treat muscle-invasive disease, a recent analysis shows similar overall survival outcomes in patients treated with chemoradiotherapy.

For those facing cancer, encouraging words can often be good medicine.

Older adults may be at an increased risk for a heart attack or stroke five months before they are even diagnosed with cancer – a risk that peaked in the month prior to diagnosis, according to a report published in Blood.

Multiple myeloma is a type of blood cancer that originates in the bones. Here’s what you need to know about the disease.

A recent survey demonstrated the common tradeoffs most patients report regarding treatment decisions, highlighting the importance of shared decision making.

The show, “New Amsterdam” features a medical director of a hospital who has cancer. He talks honestly about his cancer journey. One of the statements he made to a colleague was, “Cancer changes everything – and nothing.”

Payer reimbursement requirements, uncertainties in reform policy, and cost of new treatments viewed as top threats

The Food and Drug Administration has accepted Roche’s supplemental biologics license application for Tecentriq (atezolizumab) plus chemotherapy for the frontline treatment of patients with metastatic non-squamous non-small cell lung cancer (NSCLC) who do not have EGFR or ALK genomic tumor aberrations.

Involving patients in the decisionmaking process is an important and welcome trend, because it incorporates their values and preferences in situations where there are no black-and-white answers as to which path is best.

It would be unrealistic to suggest that one is ever completely free of the shadow of cancer – after all, shadows are the direct result of light.

There is a way to do a little self-care and still learn the latest news in cancer advocacy and science. As survivors and those affected by cancer, we should have the luxury of doing both!

Patients with cancer who have other health issues are less likely to have discussions about – and participate in – clinical trials.

I never fully understood how ingrained my children were in my soul until I had to give serious thought to the end of my own life, and I knew I didn't want to face it without them.

While celebrating Christmas this year, there was a moment that really surprised me. My youngest stepson said something about being sorry he wasn’t more help when I was going through cancer.